Clinical Trials Sponsored by Biomesight

Total 5 results

BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
Sheffield Hallam University
Symprove UK; Biomesight

Recruiting

Investigation of the Use of a Probiotic Supplement in People With Long COVID

Long COVID

United Kingdom
BioSight Ltd.

Completed

Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy (ELPIS)

Acute Myeloid Leukemia

United States, Israel
BioSight Ltd.

Active, not recruiting

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Refractory Acute Myeloid Leukemia | MDS | AML, Adult | Relapse/Recurrence

United States
BioSight Ltd.

Completed

Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (BSTPHASE1-01)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

Israel

3

Subscribe